PCO
- Product code
- PCO
- Device name
- Immunoglobulin G Lambda Heavy And Light Chain Combined
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.5510
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
FDA classification definition
Intended for the in-vitro quantification of IgG lambda concentration in human serum. The result is to be used with previously diagnosed IgG multiple myeloma, in conjunction with other clinical and laboratory findings.
Official FDA classification page: PCO
Classification and pathway per current FDA publications. Data from openFDA (CC0).